{"nct_id":"NCT03809663","title":"A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis","status":"TERMINATED","status_verified_date":"2022-03","start_date":"2019-03-15","start_date_type":"ACTUAL","primary_completion_date":"2020-05-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-12-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}